| $376M | ||
| $350M | ||
| $215M | ||
| $127M | ||
| $107M | ||
| $100M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust developmental portfolio encompasses several promising candidates: ART27.13, a synthetic G protein-coupled receptor agonist currently undergoing Phase 1b/2a clinical investigation for cancer-related anorexia; ART12.11, a synthetic cannabidiol cocrystal being explored for inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor with potential applications in prostate and breast cancer treatment, as well as PTSD. Further extending its research efforts, Artelo has established a collaborative partnership with Trinity College Dublin to probe ART27.13's efficacy in addressing cancer cachexia. Established in 2011, the entity initially operated under the name Reactive Medical, Inc. before rebranding as Artelo Biosciences, Inc. in April 2017. Its corporate headquarters are situated in Solana Beach, California.
Over the last 12 months, insiders at Artelo Biosciences, Inc. have bought $0 and sold $0 worth of Artelo Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Artelo Biosciences, Inc. have bought $9,636 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,200 shares for transaction amount of $4,800 was made by Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) on 2022‑08‑12.
| 2022-08-12 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 1,200 0.0445% | $4.00 | $4,800 | -27.57% | ||
| 2022-08-11 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 1,200 0.0456% | $4.03 | $4,836 | -26.08% | ||
| 2021-04-16 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 8,500 0.0366% | $1.15 | $9,809 | -30.80% | ||
| 2020-05-15 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 4,200 0.1219% | $1.21 | $5,072 | -5.00% | ||
| 2020-05-04 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 4,167 0.1136% | $1.20 | $5,000 | -9.45% | ||
| 2020-05-04 | MATSUI CONNIE | director | 41,667 1.1357% | $1.20 | $50,000 | -9.45% | ||
| 2019-11-04 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,400 0.0701% | $2.21 | $5,304 | -45.78% | ||
| 2019-11-01 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,500 0.0823% | $2.28 | $5,702 | -40.29% | ||
| 2019-10-31 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,500 0.0729% | $1.95 | $4,875 | -38.19% | ||
| 2019-10-30 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,600 0.0771% | $1.99 | $5,186 | -38.50% | ||
| 2019-10-15 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,600 0.0793% | $2.05 | $5,333 | -37.50% | ||
| 2019-10-11 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,700 0.0796% | $1.96 | $5,296 | -36.87% |
| MATSUI CONNIE | director | 56667 2.4282% | $74,800.44 | 1 | 0 | <0.0001% |
| Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2400 0.1028% | $3,168.00 | 11 | 0 | <0.0001% |
$1,848,072 | 66 | -14.67% | $3.38M | |
$13,690,078 | 47 | -70.44% | $3.6M | |
$1,623,655 | 34 | -17.39% | $4.61M | |
$1,138,733 | 28 | -4.94% | $4.51M | |
$8,249,886 | 17 | -47.87% | $2.75M | |
$360,130 | 16 | -21.17% | $1.57M | |
$79,536,861 | 15 | -6.81% | $4.49M | |
$742,412 | 14 | -50.36% | $4.52M | |
Artelo Biosciences, Inc. (ARTL) | $105,917 | 11 | -28.06% | $3.08M |
$245,000 | 7 | -62.00% | $2.62M | |
$40,324 | 6 | 31.82% | $4.14M | |
$70,828 | 6 | -57.96% | $2.86M | |
$726,438 | 4 | -72.85% | $2.44M | |
$157,740 | 3 | 153.95% | $2.59M | |
$14,530 | 3 | 62.23% | $4.44M | |
$4,773,558 | 2 | -65.58% | $2.06M | |
$37,000 | 1 | 79.42% | $2.81M | |
$16,800 | 1 | -55.91% | $2.02M | |
$3,300,000 | 1 | -5.51% | $4.42M |
| Increased Positions | 8 | +66.67% | 84,255 | +254.99% |
| Decreased Positions | 5 | -41.67% | 18,793 | -56.87% |
| New Positions | 6 | New | 50,837 | New |
| Sold Out Positions | 5 | Sold Out | 18,793 | Sold Out |
| Total Postitions | 15 | +25% | 98,505 | +198.11% |
| Drw Securities, Llc | $22.00 | 0.86% | 17,185 | +17,185 | New | 2025-09-30 |
| Vanguard Group Inc | $18.00 | 0.7% | 14,028 | +14,028 | New | 2025-09-30 |
| Morgan Stanley | $1.00 | 0.06% | 1,100 | +1,096 | +27,400% | 2025-09-30 |
| Citigroup Inc | $1.00 | 0.02% | 477 | +468 | +5,200% | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 209 | +120 | +134.83% | 2025-09-30 |
| Fmr Llc | $0 | <0.01% | 30 | +29 | +2,900% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 11 | +6 | +120% | 2025-09-30 |
| Rothschild Investment Llc | $0 | 0% | 2 | +2 | New | 2025-09-30 |
| Royal Bank Of Canada | $0 | 0% | 1 | 0 | 0% | 2025-09-30 |
| Danske Bank A/S | $0 | 0% | 0 | <1 | Sold Out | 2025-09-30 |